Goldman Sachs assumed coverage of Universal Health (UHS) with a Neutral rating and $219 price target The firm sees favorable trends continuing for the hospital sector through 2028, including supportive labor dynamics, tailwinds from previously approved pro-utilization government policies, and the industry showing more effective adaptation to structural changes. However, the sector will face new pressures from implementation of the One Big Beautiful Bill, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health price target raised to $249 from $210 at Wells Fargo
- Universal Health Faces $500 Million Verdict in Nevada
- Universal Health price target lowered to $250 from $259 at Barclays
- Ex-Dividend Date Nearing for These 10 Stocks – Week of September 1, 2025
- Universal Health price target raised to $206 from $201 at RBC Capital